- Home
- EXTR vs XENE Comparison
EXTR vs XENE Comparison
Compare EXTR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXTR
- XENE
- Stock Information
- Founded
- EXTR 1996
- XENE 1996
- Country
- EXTR United States
- XENE Canada
- Employees
- EXTR N/A
- XENE N/A
- Industry
- EXTR Telecommunications Equipment
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- EXTR Telecommunications
- XENE Health Care
- Exchange
- EXTR Nasdaq
- XENE Nasdaq
- Market Cap
- EXTR 2.6B
- XENE 2.9B
- IPO Year
- EXTR 1999
- XENE 2014
- Fundamental
- Price
- EXTR $22.31
- XENE $36.37
- Analyst Decision
- EXTR Strong Buy
- XENE Strong Buy
- Analyst Count
- EXTR 6
- XENE 11
- Target Price
- EXTR $21.42
- XENE $52.73
- AVG Volume (30 Days)
- EXTR 1.3M
- XENE 665.6K
- Earning Date
- EXTR 10-29-2025
- XENE 11-11-2025
- Dividend Yield
- EXTR N/A
- XENE N/A
- EPS Growth
- EXTR N/A
- XENE N/A
- EPS
- EXTR N/A
- XENE N/A
- Revenue
- EXTR $1,140,067,000.00
- XENE $7,500,000.00
- Revenue This Year
- EXTR $10.26
- XENE N/A
- Revenue Next Year
- EXTR $7.48
- XENE $256.34
- P/E Ratio
- EXTR N/A
- XENE N/A
- Revenue Growth
- EXTR 2.05
- XENE N/A
- 52 Week Low
- EXTR $10.10
- XENE $26.74
- 52 Week High
- EXTR $22.88
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- EXTR 64.15
- XENE 45.57
- Support Level
- EXTR $21.50
- XENE $38.13
- Resistance Level
- EXTR $22.89
- XENE $39.55
- Average True Range (ATR)
- EXTR 0.60
- XENE 0.97
- MACD
- EXTR 0.02
- XENE -0.47
- Stochastic Oscillator
- EXTR 77.39
- XENE 3.31
About EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.